tiprankstipranks
Trending News
More News >

TalkMed Advances CAR-T Therapy Manufacturing

TalkMed Advances CAR-T Therapy Manufacturing

TalkMed Group Ltd. (SG:5G3) has released an update.

Confident Investing Starts Here:

TalkMed Group Ltd. has announced its subsidiary BioCell Innovations Pte. Ltd.’s non-binding MOU with Thermo Fisher Scientific to improve the manufacturing of CAR-T immunotherapies in the Asia-Pacific. This collaboration aims to accelerate the development of cell therapies by leveraging BioCell’s vector design expertise and Thermo Fisher’s cell processing technologies. The company will keep its shareholders informed about significant future developments.

For further insights into SG:5G3 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1